According to Gritstone bio's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 97.4662. At the end of 2023 the company had a P/S ratio of 146.
Year | P/S ratio | Change |
---|---|---|
2023 | 146 | 370.58% |
2022 | 31.0 | 63.25% |
2021 | 19.0 | -60.5% |
2020 | 48.1 | -35.56% |
2019 | 74.7 | -80.1% |
2018 | 375 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
![]() ORIC Pharmaceuticals
ORIC | N/A | N/A | ๐บ๐ธ USA |